Neuronetics Prices $30M Offering to Address Going-Concern Risk
Neuronetics priced 18.75 million shares at $1.60 each, expecting approximately $30 million in gross proceeds before expenses. The offering is expected to close around Nov. 12, 2026. A loan prepayment of at least $15 million is a condition for amended revenue covenants that the company says would resolve going-concern risk.
Neuronetics priced an offering of 18.75M shares at $1.60 per share, with approximately $30M in gross proceeds before expenses. It expects to close around Nov. 12, 2026; a $15M-or-more loan prepayment is a condition for amended revenue covenants that it says would resolve going concern risk.Material…